pathway,nums,percent,pvalue
Focal adhesion,204,0.5882352941176471,0.0
PI3K-Akt signaling pathway,373,0.4691689008042895,0.0
Protein digestion and absorption,110,0.35454545454545455,0.0
Proteoglycans in cancer,205,0.5121951219512195,0.0
Amoebiasis,107,0.42990654205607476,0.0
ECM-receptor interaction,89,0.47191011235955055,0.001
Wnt signaling pathway,180,0.4888888888888889,0.001
Human papillomavirus infection,361,0.4986149584487535,0.002
"GABA biosynthesis, eukaryotes, putrescine => GABA",9,1.0,0.003
Adherens junction,93,0.7311827956989247,0.005
Rap1 signaling pathway,218,0.38073394495412843,0.005
Regulation of actin cytoskeleton,239,0.502092050209205,0.005
Pathways in cancer,543,0.5414364640883977,0.005
Basal cell carcinoma,63,0.4126984126984127,0.005
Hippo signaling pathway,158,0.5506329113924051,0.006
Arginine and proline metabolism,57,0.49122807017543857,0.007
Histidine metabolism,28,0.42857142857142855,0.008
Arrhythmogenic right ventricular cardiomyopathy,77,0.5454545454545454,0.008
Axon guidance,183,0.39344262295081966,0.011
Wnt signaling,38,0.42105263157894735,0.011
Tryptophan metabolism,54,0.37037037037037035,0.013
Melanogenesis,100,0.46,0.014
Salmonella infection,253,0.5770750988142292,0.015
Arrhythmogenic right ventricular cardiomyopathy (ARVC),72,0.5416666666666666,0.016
Alcoholic liver disease,141,0.46808510638297873,0.024
AGE-RAGE signaling pathway in diabetic complications,101,0.6831683168316832,0.025
Hedgehog signaling pathway,58,0.5689655172413793,0.027
Bacterial invasion of epithelial cells,76,0.18421052631578946,0.029
Relaxin signaling pathway,129,0.5116279069767442,0.032
Breast cancer,147,0.4897959183673469,0.036
Signaling pathways regulating pluripotency of stem cells,141,0.475177304964539,0.039
Efferocytosis,155,0.45161290322580644,0.043
Prostate cancer,99,0.6161616161616161,0.043
Small cell lung cancer,93,0.6559139784946236,0.047
Serotonergic synapse,133,0.3458646616541353,0.05
Tight junction,179,0.441340782122905,0.052
Hedgehog signaling,11,0.6363636363636364,0.053
Hippo signaling pathway -multiple species,26,0.6153846153846154,0.057
Phospholipase D signaling pathway,150,0.3933333333333333,0.058
Hippo signaling pathway - multiple species,27,0.5555555555555556,0.061
Neuroactive ligand-receptor interaction,393,0.11195928753180662,0.068
Gastric cancer,150,0.4866666666666667,0.079
Hippo signaling,15,0.8,0.082
Endometrial cancer,58,0.6551724137931034,0.102
Cushing syndrome,162,0.46296296296296297,0.108
"Ribosome, eukaryotes",98,0.1836734693877551,0.12
mTOR signaling pathway,158,0.16455696202531644,0.123
Cocaine addiction,48,0.5208333333333334,0.128
"Glycine, serine and threonine metabolism",40,0.525,0.134
Hepatocellular carcinoma,174,0.5689655172413793,0.135
Central carbon metabolism in cancer,69,0.37681159420289856,0.148
Kaposi sarcoma-associated herpesvirus infection,223,0.4798206278026906,0.149
Dopaminergic synapse,138,0.5289855072463768,0.157
Ribosome,187,0.18181818181818182,0.159
Phenylalanine metabolism,24,0.4583333333333333,0.17
Thyroid cancer,37,0.6486486486486487,0.171
Colorectal cancer,88,0.6704545454545454,0.173
JAK-STAT signaling pathway,171,0.15789473684210525,0.175
Platelet activation,126,0.38095238095238093,0.182
Diabetic cardiomyopathy,211,0.23696682464454977,0.189
Leukocyte transendothelial migration,121,0.34710743801652894,0.2
Neurotrophin signaling pathway,121,0.3305785123966942,0.248
Toxoplasmosis,109,0.30275229357798167,0.267
Coronavirus disease - COVID-19,249,0.20883534136546184,0.271
mmuK signaling pathway,301,0.31561461794019935,0.272
Apoptosis,137,0.30656934306569344,0.3
Acute myeloid leukemia,70,0.5571428571428572,0.307
Tyrosine metabolism,41,0.43902439024390244,0.316
Jak-STAT signaling pathway,159,0.1949685534591195,0.32
Ras signaling pathway,242,0.12396694214876033,0.369
Drug metabolism - cytochrome P450,72,0.3333333333333333,0.371
Inflammatory bowel disease,62,0.1774193548387097,0.39
EGFR tyrosine kinase inhibitor resistance,79,0.3924050632911392,0.394
Sphingolipid signaling pathway,127,0.5826771653543307,0.404
Base excision repair,49,0.14285714285714285,0.416
Ferroptosis,42,0.42857142857142855,0.418
Calcium signaling pathway,254,0.16929133858267717,0.43
Chemokine signaling pathway,204,0.24019607843137256,0.432
Measles,145,0.27586206896551724,0.451
MAPK signaling pathway,252,0.3333333333333333,0.457
Insulin resistance,110,0.2636363636363636,0.457
Amphetamine addiction,69,0.5362318840579711,0.46
p53 signaling pathway,74,0.25675675675675674,0.461
Amyotrophic lateral sclerosis,369,0.21951219512195122,0.479
GABAergic synapse,91,0.04395604395604396,0.483
Alcoholism,205,0.2731707317073171,0.501
Glutamatergic synapse,116,0.04310344827586207,0.513
Thermogenesis,231,0.15151515151515152,0.515
Nucleotide excision repair,58,0.10344827586206896,0.527
Ubiquitin mediated proteolysis,151,0.07947019867549669,0.528
Parkinson disease,264,0.5454545454545454,0.544
Metabolic pathways,1315,0.44106463878326996,0.548
Polycomb repressive complex,84,0.2976190476190476,0.56
Glycosaminoglycan biosynthesis - heparan sulfate / heparin,24,0.20833333333333334,0.572
HIF-1 signaling pathway,120,0.275,0.575
NF-kappa B signaling pathway,114,0.07894736842105263,0.59
Human T-cell leukemia virus 1 infection,249,0.2570281124497992,0.6
Choline metabolism in cancer,98,0.24489795918367346,0.608
Non-small cell lung cancer,72,0.4166666666666667,0.609
Survival motor neuron (SMN) complex,9,0.3333333333333333,0.611
ATP-dependent chromatin remodeling,136,0.08088235294117647,0.623
Pancreatic cancer,76,0.5263157894736842,0.628
Fluid shear stress and atherosclerosis,147,0.2925170068027211,0.628
Fc gamma R-mediated phagocytosis,97,0.1958762886597938,0.631
Cell cycle - G1/S transition,13,0.3076923076923077,0.642
TNF signaling pathway,115,0.09565217391304348,0.645
Mismatch repair,22,0.18181818181818182,0.657
Herpes simplex virus 1 infection,458,0.13537117903930132,0.661
Necroptosis,175,0.21142857142857144,0.675
Mucin type O-glycan biosynthesis,32,0.28125,0.676
Viral life cycle - HIV-1,61,0.22950819672131148,0.676
RNA transport,167,0.1377245508982036,0.68
Viral carcinogenesis,228,0.27631578947368424,0.682
Cell cycle,157,0.3184713375796178,0.686
Hepatitis C,166,0.3072289156626506,0.696
Inflammatory bowel disease (IBD),59,0.1864406779661017,0.699
NOD-like receptor signaling pathway,220,0.07272727272727272,0.7
Bladder cancer,41,0.34146341463414637,0.7
Huntington disease,302,0.2251655629139073,0.713
Herpes simplex infection,215,0.15348837209302327,0.726
Proteasome,47,0.2127659574468085,0.726
Immunoproteasome,18,0.2777777777777778,0.739
Protein processing in endoplasmic reticulum,183,0.18032786885245902,0.744
JAK-STAT signaling,19,0.5263157894736842,0.747
Endocrine resistance,93,0.40860215053763443,0.759
Th17 cell differentiation,107,0.21495327102803738,0.781
Glioma,74,0.33783783783783783,0.783
Cellular senescence,183,0.3114754098360656,0.793
Mitophagy - animal,68,0.38235294117647056,0.803
Chemical carcinogenesis - receptor activation,225,0.26666666666666666,0.814
RNA degradation,90,0.15555555555555556,0.822
Lipid and atherosclerosis,216,0.28703703703703703,0.822
FoxO signaling pathway,133,0.2706766917293233,0.825
Epstein-Barr virus infection,230,0.28695652173913044,0.827
Homologous recombination,42,0.2619047619047619,0.839
Thyroid hormone signaling pathway,120,0.31666666666666665,0.841
Transcriptional misregulation in cancer,224,0.36160714285714285,0.851
Fanconi anemia pathway,51,0.27450980392156865,0.857
Adipocytokine signaling pathway,73,0.2465753424657534,0.868
PD-L1 expression and PD-1 checkpoint pathway in cancer,88,0.29545454545454547,0.868
"Growth hormone synthesis, secretion and action",117,0.3247863247863248,0.87
MicroRNAs in cancer,303,0.22112211221122113,0.878
HTLV-I infection,283,0.254416961130742,0.879
Huntington's disease,194,0.28865979381443296,0.894
Human cytomegalovirus infection,255,0.32941176470588235,0.897
Prolactin signaling pathway,74,0.33783783783783783,0.899
Spliceosome,186,0.03763440860215054,0.905
Glycosphingolipid biosynthesis - ganglio series,15,0.4666666666666667,0.916
"Spliceosome, U4/U6.U5 tri-snRNP",32,0.09375,0.923
Longevity regulating pathway,90,0.32222222222222224,0.925
Platinum drug resistance,80,0.45,0.954
Melanoma,72,0.2916666666666667,0.973
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,21,0.6190476190476191,0.985
Amyotrophic lateral sclerosis (ALS),52,0.19230769230769232,0.988
Hepatitis B,163,0.4110429447852761,0.991
Chronic myeloid leukemia,76,0.39473684210526316,0.995
Motor proteins,196,0.2755102040816326,1.0
